1. Home
  2. MDWD vs CLAR Comparison

MDWD vs CLAR Comparison

Compare MDWD & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • CLAR
  • Stock Information
  • Founded
  • MDWD 2000
  • CLAR 1957
  • Country
  • MDWD Israel
  • CLAR United States
  • Employees
  • MDWD N/A
  • CLAR N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • CLAR Recreational Games/Products/Toys
  • Sector
  • MDWD Health Care
  • CLAR Consumer Discretionary
  • Exchange
  • MDWD Nasdaq
  • CLAR Nasdaq
  • Market Cap
  • MDWD 184.8M
  • CLAR 173.0M
  • IPO Year
  • MDWD 2014
  • CLAR N/A
  • Fundamental
  • Price
  • MDWD $18.41
  • CLAR $4.81
  • Analyst Decision
  • MDWD Strong Buy
  • CLAR Strong Buy
  • Analyst Count
  • MDWD 1
  • CLAR 3
  • Target Price
  • MDWD $25.00
  • CLAR $6.33
  • AVG Volume (30 Days)
  • MDWD 65.3K
  • CLAR 139.0K
  • Earning Date
  • MDWD 11-26-2024
  • CLAR 03-06-2025
  • Dividend Yield
  • MDWD N/A
  • CLAR 2.07%
  • EPS Growth
  • MDWD N/A
  • CLAR N/A
  • EPS
  • MDWD N/A
  • CLAR 0.13
  • Revenue
  • MDWD $19,720,000.00
  • CLAR $269,413,000.00
  • Revenue This Year
  • MDWD $10.37
  • CLAR N/A
  • Revenue Next Year
  • MDWD $26.36
  • CLAR $9.30
  • P/E Ratio
  • MDWD N/A
  • CLAR $38.21
  • Revenue Growth
  • MDWD N/A
  • CLAR 48.98
  • 52 Week Low
  • MDWD $11.04
  • CLAR $3.89
  • 52 Week High
  • MDWD $24.00
  • CLAR $7.55
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 54.87
  • CLAR 60.25
  • Support Level
  • MDWD $17.47
  • CLAR $4.30
  • Resistance Level
  • MDWD $19.60
  • CLAR $4.65
  • Average True Range (ATR)
  • MDWD 0.99
  • CLAR 0.16
  • MACD
  • MDWD 0.07
  • CLAR 0.03
  • Stochastic Oscillator
  • MDWD 68.68
  • CLAR 91.07

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a global leader in designing, manufacturing, and marketing innovative outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of highly-engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.

Share on Social Networks: